February 2014 Product Spotlight: Infectious Disease Testing
Products range from the Nanosphere Verigene BC-GN test to a tissue preparation solution from Siemens.
Read MorePosted by Jenny Lower | Feb 28, 2014 | Infectious Diseases |
Products range from the Nanosphere Verigene BC-GN test to a tissue preparation solution from Siemens.
Read MorePosted by Steve Halasey | Feb 25, 2014 | Research |
A newly published study of a molecular diagnostic test by Myriad Genetics has demonstrated that the test can accurately predict which men will develop biochemical recurrence or metastatic disease following radical prostate surgery.
Read MorePosted by Steve Halasey | Feb 18, 2014 | Molecular Diagnostics |
FDA has granted premarket notification (510(k)) clearance for the CytoScan Dx assay, a new test intended for the postnatal detection of DNA copy-number variants in patients referred for chromosomal testing.
Read MorePosted by Steve Halasey | Feb 11, 2014 | Cancer, Research |
A pilot program in clinical genomics will allow a small group of patients at Stanford Hospital and Clinics and Lucile Packard Children’s Hospital Stanford to have their DNA deciphered to help doctors with diagnosis and treatment.
Read MorePosted by Jenny Lower | Jan 28, 2014 | Uncategorized |
New products include the Cytation 3 cell imaging multi-mode reader by BioTek and the myPlan Lung Cancer test from Myriad.
Read More